Newswise — Washington, DC (August 24, 2022) — KidneyCure is happy to announce the most recent addition to its Transition to Independence Grants Program: The KidneyCure Variety, Fairness, Inclusion, and Justice Analysis Scholar Grant.

Established with a $1 million donation from Otsuka and Visterra that the American Society of Nephrology (ASN) will match to assist endow, this grant shall be awarded each different yr starting in 2023. It’s KidneyCure’s first grant designated for an ASN member who identifies as underrepresented in drugs or is conducting analysis centered on range, fairness, inclusion, or justice.

“It’s crucial that medical analysis is grounded in science and improvements which are fueled by range of backgrounds, experiences and ideas,” stated Robert McQuade, PhD, government vp, chief strategic officer, and interim chief medical officer at Otsuka Pharmaceutical Growth & Commercialization, Inc. “Otsuka and Visterra are happy to help the institution of the KidneyCure Variety, Fairness, Inclusion, and Justice Analysis Scholar Grant,” added Brian J. G. Pereira, MD, CEO of Visterra, Inc.

KidneyCure is devoted to retaining gifted investigators within the discipline of nephrology and on observe to creating groundbreaking discoveries. The muse distributes greater than $three million yearly to early-career investigators and educators by means of 5 totally different grant packages.

“This grant is vital to the way forward for nephrology and to the care of numerous populations of people with kidney illnesses,” stated ASN Previous President and present KidneyCure Board Chair Anupam Agarwal, MD, FASN. “The advances that it’s going to help will align with ASN’s dedication to range, inclusion, justice, and innovation.”

Because it was established in 1996, the Transition to Independence Grants Program has been the cornerstone of the inspiration’s portfolio. This system offers funding to foster junior college transitions to unbiased analysis careers and profitable purposes for Nationwide Institutes of Well being R01 grants or equal. Via this program, KidneyCure helps candidates who present probably the most promise in producing modern analysis to advance nephrology. As much as 10 new and 10 persevering with grants are awarded yearly at $100,000 a yr for 2 years. Since 1996, the Transition to Independence Grants Program has funded 213 researchers.

Purposes for this grant shall be accepted this fall. For extra data, please go to www.kidneycure.org.  

About KidneyCure

Established in 2012, KidneyCure funds the Ben J. Lipps Analysis Fellowship Program, the Transition to Independence Grants Program, the William and Sandra Bennett Medical Students Program, the American Society of Nephrology-Harold Amos Medical School Growth Program, and the ASN Pre-Doctoral Fellowship Award Program. For extra data, go to www.kidneycure.org, contact [email protected], or name (202) 640-4660.

About ASN

Since 1966, ASN has been main the combat to stop, deal with, and treatment kidney illnesses all through the world by educating well being professionals and scientists, advancing analysis and innovation, speaking new data, and advocating for the best high quality take care of sufferers. ASN has greater than 20,000 members representing 132 nations. For extra data, go to www.asn-online.org and comply with us on Fb, Twitter, LinkedIn, and Instagram.

About Otsuka

Otsuka Pharmaceutical Co., Ltd. is a world healthcare firm with the company philosophy: “Otsuka–individuals creating new merchandise for higher well being worldwide.” Otsuka researches, develops, manufactures, and markets modern merchandise, with a concentrate on pharmaceutical merchandise to satisfy unmet medical wants and nutraceutical merchandise for the upkeep of on a regular basis well being.  

In prescription drugs, Otsuka is a pacesetter within the difficult areas of psychological, renal, and cardiovascular well being and has further analysis packages in oncology and on a number of under-addressed illnesses together with tuberculosis, a major world public well being difficulty. 

The Otsuka group of corporations employed 47,000 individuals worldwide and had consolidated gross sales of roughly USD 13.6 billion in 2021.  

All Otsuka tales begin by taking the street much less traveled. Be taught extra about Otsuka within the U.S. at www.otsuka-us.com and join with us on LinkedIn and Twitter at @OtsukaUS. Otsuka Pharmaceutical Co., Ltd.’s world web site is accessible at www.otsuka.co.jp/en/. 

About Visterra, Inc.

Visterra is a biologics analysis and early-stage medical growth firm growing therapies for sufferers with immune-mediated and different hard-to-treat medical circumstances. A member of the Otsuka group of corporations since 2018, Visterra was based in 2007 and is positioned in Waltham, Massachusetts.